| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 300.00 |
P174144
Closed
Stefka Slavova , Ali H. Abukumail
Small and Medium Enterprises Development Organization of Turkey/Küçük ve Orta Ölçekli ??let
October 16, 2020
(as of board presentation)
December 18, 2020
April 23, 2021
US$ 300.00 million
Small and Medium Enterprises Development Organization of Turkey/Küçük ve Orta Ölçekli ??let
2021
US$ 300.00 million
N/A
Moderate
June 30, 2023
Yes
Bank Approved
January 1, 2024
| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 300.00 |
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 300.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 300.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 300.00 |
| Name | Review | Date |
|---|---|---|
| Financial Management | Satisfactory | 2022-11-24 |
| Monitoring and Evaluation | Satisfactory | 2022-11-24 |
| Overall Implementation Progress (IP) | Satisfactory | 2022-11-24 |
| Procurement | Satisfactory | 2022-11-24 |
| Progress towards achievement of PDO | Satisfactory | 2022-11-24 |
| Project Management | Satisfactory | 2022-11-24 |
| INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 12-21-2023 |
|---|---|
| Outcomes | Highly Satisfactory |
| Risk to Development Outcome | |
| Bank Performance | Highly Satisfactory |
| Borrower Performance | |
| Government Performance | |
| Implementing Agency |
| INDICATOR | ICR REVIEW: 06-03-2024 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
|---|---|---|
| Outcome Rating | Highly Satisfactory | N/a |
| Risk To Development Outcome | N/a | |
| Bank Performance | Satisfactory | N/a |
| Borrower Performance | N/a | |
| Government Performance | N/a | |
| Implementing Agency | N/a | |
| Icr Quality | Substantial | N/a |
| M&e Quality | Substantial | N/a |
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
| Share of beneficiary MSEs that survive the COVID-19 crisis for at least six months after receiving performance-based reimbursable support financing | Value | 0.00 | 97.63 | 25.00 |
| Date | July 27, 2020 | October 5, 2022 | May 31, 2022 | |
| Comment |
| Share of beneficiary innovative young firms that survive the COVID-19 crisis for at least six months after receiving performance-based reimbursable support financing | Value | 0.00 | 96.97 | 20.00 |
| Date | July 27, 2020 | October 5, 2022 | May 31, 2022 | |
| Comment |
| Share of beneficiary surviving MSEs that increase employment relative to the average employment level of the MSE for the 12-month period preceding on which the app [see description for full name] | Value | 0.00 | 83.17 | 25.00 |
| Date | July 27, 2020 | October 5, 2022 | May 31, 2022 | |
| Comment |
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
| KOSGEB Firm Engagement: Beneficiary firms reporting that the provided reimbursable support financing reflected their needs | Value | 0.00 | 90.00 | 30.00 |
| Date | July 27, 2020 | June 30, 2022 | January 31, 2022 | |
| Comment |
| KOSGEB Firm Engagement: Beneficiary young firms reporting that the provided reimbursable support financing reflected their needs | Value | 0.00 | 86.00 | 30.00 |
| Date | July 27, 2020 | June 30, 2022 | May 31, 2022 | |
| Comment |
| Of applicants that are female-led or -owned MSEs or with female majority workforce, share that meet the eligibility criteria and receive reimbursable support financing | Value | 0.00 | 62.00 | 20.00 |
| Date | July 27, 2020 | June 30, 2022 | May 31, 2022 | |
| Comment |
| Of applicants that are female-led or -owned young innovative MSEs or with female majority workforce, share that meet the eligibility criteria and receive reimbursable support financing | Value | 0.00 | 78.00 | 20.00 |
| Date | July 27, 2020 | June 30, 2022 | May 31, 2022 | |
| Comment |